S. KADAYIFÇILAR Et Al. , "Current therapy for choroidal neovascularization in pathologic myopia photodynamic therapy and or intravitreal bevacizumab," European Society of Ophthalmology , Amsterdam, Netherlands, 2009
KADAYIFÇILAR, S. Et Al. 2009. Current therapy for choroidal neovascularization in pathologic myopia photodynamic therapy and or intravitreal bevacizumab. European Society of Ophthalmology , (Amsterdam, Netherlands).
KADAYIFÇILAR, S., ÇELEBİ, A. R. C., & ELDEM, M. B., (2009). Current therapy for choroidal neovascularization in pathologic myopia photodynamic therapy and or intravitreal bevacizumab . European Society of Ophthalmology, Amsterdam, Netherlands
KADAYIFÇILAR, SİBEL, ALİ RIZA CENK ÇELEBİ, And MEHMET BORA ELDEM. "Current therapy for choroidal neovascularization in pathologic myopia photodynamic therapy and or intravitreal bevacizumab," European Society of Ophthalmology, Amsterdam, Netherlands, 2009
KADAYIFÇILAR, SİBEL Et Al. "Current therapy for choroidal neovascularization in pathologic myopia photodynamic therapy and or intravitreal bevacizumab." European Society of Ophthalmology , Amsterdam, Netherlands, 2009
KADAYIFÇILAR, S. ÇELEBİ, A. R. C. And ELDEM, M. B. (2009) . "Current therapy for choroidal neovascularization in pathologic myopia photodynamic therapy and or intravitreal bevacizumab." European Society of Ophthalmology , Amsterdam, Netherlands.
@conferencepaper{conferencepaper, author={SİBEL KADAYIFÇILAR Et Al. }, title={Current therapy for choroidal neovascularization in pathologic myopia photodynamic therapy and or intravitreal bevacizumab}, congress name={European Society of Ophthalmology}, city={Amsterdam}, country={Netherlands}, year={2009}}